Edition:
United States

Leisure & Recreation

Page 2

Unlimited Travel Group launches UTG Reseproduktion

Monday, 16 Mar 2015 11:20am EDT

Unlimited Travel Group UTG AB publ:Launches UTG Reseproduktion, a new business within Unlimited Travel Group.

RestorGenex Corp granted orphan drug designation for RES-529 for treatment of Glioblastoma Multiforme

Wednesday, 28 Jan 2015 07:00am EST

RestorGenex Corp:Says US FDA has granted orphan drug designation for RES-529 for treatment of glioblastoma multiforme.Orphan drug designation, as granted by U.S. Orphan Drug Act, is for a product to treat rare disease or condition that affects fewer than 200,000 people in United States.Orphan drug designation qualifies sponsor of product for tax credit and seven years of marketing exclusivity.Says RES-529 is a first-in-class inhibitor of the PI3K/Akt/mTOR pathway.Signaling components of PI3K pathway are central regulators of cell proliferation, growth, differentiation, survival and angiogenesis.Up to 80 pct of tumor types have been shown to have an aberrant up-regulation of the PI3K pathway.Activation of this pathway has been observed in glioblastoma patients thus making PI3K pathway inhibition a validated target for therapeutic intervention in glioblastoma multiforme.

RestorGenex announces issuance of european patent for its dermatology program

Monday, 5 Jan 2015 07:00am EST

RestorGenex Corp:Says European Patent Office has issued to RestorGenex European Patent No. 2364700 entitled Compositions and Methods to Treat Skin Diseases Characterized by Cellular Proliferation and Angiogenesis.Patent is directed to use of RES-529, as well as other small molecules, for preventing or treating skin diseases, as well as on the composition of matter of RES-529.RES-529 is first-in-class allosteric dissociative TORC1/TORC2 inhibitor of the PI3K pathway, and is RestorGenex's lead candidate in development for treatment of diseases involving cell proliferation and angiogenesis.Patent adds EU protection to RestorGenex's intellectual property portfolio related to RES-529 that includes U.S. Patent No. 8,475,776 which provides both composition of matter and method of use protection for RES-529 in U.S.

Tuniu Corp adds ten new regional service centers

Monday, 8 Dec 2014 09:30pm EST

Tuniu Corp:Says that it has set up 10 new regional service centers, significantly expanding its coverage of lower tier cities in China.With additional service centers in Luoyang, Lanzhou, Nanchong, Datong, Huzhou, Yichang, Zhuzhou, Zhangzhou, Taizhou and Deyang, Tuniu now has a total of 60 regional service centers throughout China.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Analyst Research

Report Title Price
Provider : Edison Investment Research
$10.00
Provider : Edison Investment Research
$10.00
Provider : Edison Investment Research
$10.00
Provider : Edison Investment Research
$10.00
Provider : Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.